Goldenwell Biotech (GWLL) Debt Ratio (2023 - 2025)

Goldenwell Biotech has reported Debt Ratio for 3 years, with the latest figure at 0.5 in Q1 2025.

• For the quarter ending Q1 2025, Debt Ratio changed N/A year-over-year to 0.5; the trailing twelve-month figure through Mar 2025 stood at 0.5 (changed N/A YoY), and the FY2024 full-year result was 0.43, up 28.66% from the prior year.
• Debt Ratio for Q1 2025 stood at 0.5, up from 0.43 in the prior quarter.
• The five-year high for Debt Ratio was 0.5 in Q1 2025, with the low at 0.33 in Q4 2023.
• Historically, Debt Ratio has averaged 0.42 across 3 years, with a median of 0.43 in 2024.
• The largest YoY upside for Debt Ratio was 28.66% in 2024 against a maximum downside of 28.66% in 2024.
• Goldenwell Biotech's Debt Ratio stood at 0.33 in 2023, then rose by 28.66% to 0.43 in 2024, then advanced by 16.82% to 0.5 in 2025.
• The last three Debt Ratio figures came in at 0.5 (Q1 2025), 0.43 (Q4 2024), and 0.33 (Q4 2023), per Business Quant data.